Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136


Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X.

Arpone M, Baker EK, Bretherton L, Bui M, Li X, Whitaker S, Dissanayake C, Cohen J, Hickerton C, Rogers C, Field M, Elliott J, Aliaga SM, Ling L, Francis D, Hearps SJC, Hunter MF, Amor DJ, Godler DE.

Sci Rep. 2018 Feb 26;8(1):3644. doi: 10.1038/s41598-018-21990-x.


Control of recollection by slow gamma dominating mid-frequency gamma in hippocampus CA1.

Dvorak D, Radwan B, Sparks FT, Talbot ZN, Fenton AA.

PLoS Biol. 2018 Jan 18;16(1):e2003354. doi: 10.1371/journal.pbio.2003354. eCollection 2018 Jan.


Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity.

Gilbert J, Man HY.

Front Cell Neurosci. 2017 Nov 20;11:359. doi: 10.3389/fncel.2017.00359. eCollection 2017. Review.


The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.

Zalfa F, Panasiti V, Carotti S, Zingariello M, Perrone G, Sancillo L, Pacini L, Luciani F, Roberti V, D'Amico S, Coppola R, Abate SO, Rana RA, De Luca A, Fiers M, Melocchi V, Bianchi F, Farace MG, Achsel T, Marine JC, Morini S, Bagni C.

Cell Death Dis. 2017 Nov 16;8(11):e3169. doi: 10.1038/cddis.2017.521.


Effects of regulatory BC1 RNA deletion on synaptic plasticity, learning, and memory.

Chung A, Dahan N, Alarcon JM, Fenton AA.

Learn Mem. 2017 Nov 15;24(12):646-649. doi: 10.1101/lm.045617.117. Print 2017 Dec.


Cell Type-Specific mRNA Dysregulation in Hippocampal CA1 Pyramidal Neurons of the Fragile X Syndrome Mouse Model.

Ceolin L, Bouquier N, Vitre-Boubaker J, Rialle S, Severac D, Valjent E, Perroy J, Puighermanal E.

Front Mol Neurosci. 2017 Oct 20;10:340. doi: 10.3389/fnmol.2017.00340. eCollection 2017.


Molecular underpinnings of neurodegenerative disorders: striatal-enriched protein tyrosine phosphatase signaling and synaptic plasticity.

Lombroso PJ, Ogren M, Kurup P, Nairn AC.

F1000Res. 2016 Dec 29;5. pii: F1000 Faculty Rev-2932. doi: 10.12688/f1000research.8571.1. eCollection 2016. Review.


Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation.

Henry FE, Hockeimer W, Chen A, Mysore SP, Sutton MA.

Mol Brain. 2017 Oct 30;10(1):50. doi: 10.1186/s13041-017-0330-y.


Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.

Aloisi E, Le Corf K, Dupuis J, Zhang P, Ginger M, Labrousse V, Spatuzza M, Georg Haberl M, Costa L, Shigemoto R, Tappe-Theodor A, Drago F, Vincenzo Piazza P, Mulle C, Groc L, Ciranna L, Catania MV, Frick A.

Nat Commun. 2017 Oct 24;8(1):1103. doi: 10.1038/s41467-017-01191-2.


Altered Developmental Expression of the Astrocyte-Secreted Factors Hevin and SPARC in the Fragile X Mouse Model.

Wallingford J, Scott AL, Rodrigues K, Doering LC.

Front Mol Neurosci. 2017 Aug 29;10:268. doi: 10.3389/fnmol.2017.00268. eCollection 2017.


Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.

Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA; FragXis Study Group.

Neuropsychopharmacology. 2018 Feb;43(3):503-512. doi: 10.1038/npp.2017.177. Epub 2017 Aug 17.


Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.

Haas LT, Salazar SV, Smith LM, Zhao HR, Cox TO, Herber CS, Degnan AP, Balakrishnan A, Macor JE, Albright CF, Strittmatter SM.

Cell Rep. 2017 Jul 5;20(1):76-88. doi: 10.1016/j.celrep.2017.06.023.


Arbaclofen in fragile X syndrome: results of phase 3 trials.

Berry-Kravis E, Hagerman R, Visootsak J, Budimirovic D, Kaufmann WE, Cherubini M, Zarevics P, Walton-Bowen K, Wang P, Bear MF, Carpenter RL.

J Neurodev Disord. 2017 Jun 12;9:3. doi: 10.1186/s11689-016-9181-6. eCollection 2017.


Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases.

Koon AC, Chan HY.

Front Cell Neurosci. 2017 Mar 21;11:70. doi: 10.3389/fncel.2017.00070. eCollection 2017. Review.


β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.

Stoppel LJ, Auerbach BD, Senter RK, Preza AR, Lefkowitz RJ, Bear MF.

Cell Rep. 2017 Mar 21;18(12):2807-2814. doi: 10.1016/j.celrep.2017.02.075.


Cell type-dependent axonal localization of translational regulators and mRNA in mouse peripheral olfactory neurons.

Korsak LIT, Shepard KA, Akins MR.

J Comp Neurol. 2017 Jun 15;525(9):2202-2215. doi: 10.1002/cne.24199. Epub 2017 Mar 26.


Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains.

Akins MR, Berk-Rauch HE, Kwan KY, Mitchell ME, Shepard KA, Korsak LI, Stackpole EE, Warner-Schmidt JL, Sestan N, Cameron HA, Fallon JR.

Hum Mol Genet. 2017 Jan 1;26(1):192-209. doi: 10.1093/hmg/ddw381.


Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction.

Ahmad M, Shen W, Li W, Xue Y, Zou S, Xu D, Wang W.

Nucleic Acids Res. 2017 Mar 17;45(5):2704-2713. doi: 10.1093/nar/gkw1293.


Wnt signaling networks in autism spectrum disorder and intellectual disability.

Kwan V, Unda BK, Singh KK.

J Neurodev Disord. 2016 Dec 5;8:45. eCollection 2016. Review.


Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome.

Tao J, Wu H, Coronado AA, de Laittre E, Osterweil EK, Zhang Y, Bear MF.

J Neurosci. 2016 Nov 23;36(47):11946-11958.

Supplemental Content

Support Center